T. Rowe Price Investment Management, Inc.

Position in JNJ — Johnson & Johnson

CIK 1897612 BALTIMORE, MD

Back to JNJ Full portfolio

Position in JNJ

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,137,147

+$1,260,542 QoQ

Shares Held

16,925

+21.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

T. Rowe Price Investment Management, Inc. holds $1,197,745,873 across 8 Drug Manufacturers - General names. JNJ ranks #4 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,026,556	$944,195,412
2	BIIB	Biogen Inc.	1,160,989	$212,844,113
3	GILD	Gilead Sciences, Inc.	230,625	$32,142,206
4	JNJ	Johnson & Johnson This page	16,925	$4,137,147
5	ABBV	AbbVie Inc.	5,805	$1,262,529
6	BMY	Bristol Myers Squibb Co	19,177	$1,163,085
7	PFE	Pfizer Inc	35,847	$1,006,583
8	MRK	Merck & Co., Inc.	8,270	$994,798

All Filings in JNJ

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,137,147	16,925	+21.8%	Shares	Sole	2026-05-15
2025-12-31	$2,876,605	13,900	+84.4%	Shares	Sole	2026-02-19
2025-09-30	$1,397,325	7,536	-98.8%	Shares	Sole	2025-11-14
2025-06-30	$95,772,722	626,990	+1.5%	Shares	Sole	2025-08-14
2025-03-31	$102,459,932	617,824	+25815.4%	Shares	Sole	2025-05-14
2024-06-30	$348,445	2,384	0.0%	Shares	Sole	2024-08-14
2024-03-31	$377,124	2,384	+30.4%	Shares	Sole	2024-05-15
2023-12-31	$286,520	1,828	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.